Publicaciones

HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions.

Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice.

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.

Evolution of cervical cytologic changes among HIV-infected women with normal cytology in the HAART era.

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.

Update of the drug resistance mutations in HIV-1: Fall 2006.

Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients.

Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.

[Resistance genotyping in patients with therapeutic failure].

Naive CD4(+) T cells and recent thymic emigrant levels in treated individuals with HIV: clinical relevance.